Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Hypersensitivity Reaction |
Free Subscription
1 Acta Derm Venereol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Hypersensitivity Reaction is free of charge.
Tralokinumab as an Alternative to Dupilumab in a Patient with Atopic Dermatitis
and Asthma who Developed Hypereosinophilia: A Case Report.
Acta Derm Venereol. 2024;104:adv40800.
PubMed
An algorithm for the diagnosis and management of IgE-mediated food allergy, 2024
update.
Allergy. 2024 Sep 20. doi: 10.1111/all.16321.
PubMed
HLA-DR(+) regulatory T cells and IL-10 are associated with success or failure of
desensitization outcomes.
Allergy. 2024 Sep 18. doi: 10.1111/all.16311.
PubMed
Abstract available
Omalizumab reduces anaphylactic reactions and allows food introduction in
food-allergic in children with severe asthma: An observational study.
Allergy. 2024 Sep 16. doi: 10.1111/all.16314.
PubMed
Abstract available
Expansion of phenotypically modified type 2 memory B cells after allergen
immunotherapy.
Allergy. 2024 Sep 13. doi: 10.1111/all.16320.
PubMed
Essentials of an immunodeficiency primer: A practical reference for the
allergist/immunologist and the allergy-immunology fellow-in-training (FIT).
Allergy Asthma Proc. 2024;45:291-293.
PubMed
Asthma Inception: Epidemiologic Risk Factors and Natural History Across the
Life-Course.
Am J Respir Crit Care Med. 2024 Jul 9. doi: 10.1164/rccm.202312-2249.
PubMed
Abstract available
Unveiling the Neuron-Mediated ILC2 Activation in Human Asthma.
Am J Respir Crit Care Med. 2024 May 31. doi: 10.1164/rccm.202404-0844.
PubMed
Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in
Mild Asthma.
Am J Respir Crit Care Med. 2024 Apr 10. doi: 10.1164/rccm.202311-2164.
PubMed
Abstract available
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary
Fibrosis Foundation Registry.
Am J Respir Crit Care Med. 2024;210:801-813.
PubMed
Abstract available
Eosinophilic esophagitis in Native American children and young adults: A case
control study.
Ann Allergy Asthma Immunol. 2024;133:476-480.
PubMed
A retrospective study of a novel 3-session rush venom immunotherapy protocol.
Ann Allergy Asthma Immunol. 2024;133:462-468.
PubMed
Abstract available
Sex differences in sociodemographic, clinical, and laboratory variables in
childhood asthma: A birth cohort study.
Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
PubMed
Abstract available
Race toward more equitable pulmonary function testing?
Ann Allergy Asthma Immunol. 2024;133:362-363.
PubMed
Real-world unified airway benefits of mepolizumab: effectiveness in patients with
asthma and comorbid nasal polyps.
Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
PubMed
Abstract available
Nonsteroidal anti-inflammatory drug-induced fixed urticaria: First pediatric case
report.
Ann Allergy Asthma Immunol. 2024;133:470-472.
PubMed
Blood stored in EDTA tubes provides accurate peanut basophil activation test
results for 48 hours.
Ann Allergy Asthma Immunol. 2024;133:445-452.
PubMed
Abstract available
Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy
Implementation and Resultant Programming.
Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
PubMed
Abstract available
Topical corticosteroids for hives and itch (urticaria): Systematic review and
Bayesian meta-analysis of randomized trials.
Ann Allergy Asthma Immunol. 2024;133:437-444.
PubMed
Abstract available
The future of targeted therapy in chronic spontaneous urticaria.
Ann Allergy Asthma Immunol. 2024;133:367-373.
PubMed
Abstract available
Clinical and inflammatory features of traffic-related diesel exposure in children
with asthma.
Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
PubMed
Abstract available
Parasympathetic nervous system: a key role in control and mood disorders in
patients with asthma.
Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
PubMed
Abstract available
The landscape of novel therapies for urticaria and angioedema.
Ann Allergy Asthma Immunol. 2024;133:355.
PubMed
Biologics for asthma and comorbid nasal polyps.
Ann Allergy Asthma Immunol. 2024;133:356-357.
PubMed
Topical corticosteroids for urticaria: A look at the evidence we have.
Ann Allergy Asthma Immunol. 2024;133:358-359.
PubMed
Venom immunotherapy: What is the rush?
Ann Allergy Asthma Immunol. 2024;133:360-361.
PubMed
Comment on "Multiple reactions during desensitization may predict decreased
efficacy of PEGasparaginase chemotherapy".
Ann Allergy Asthma Immunol. 2024;133:484-485.
PubMed
Management of Anaphylaxis Following Pre-Hospital Epinephrine Use in Children with
Food-induced Anaphylaxis.
Ann Allergy Asthma Immunol. 2024 Sep 18:S1081-1206(24)01528.
PubMed
Abstract available
The future of therapeutic options for hereditary angioedema.
Ann Allergy Asthma Immunol. 2024;133:380-390.
PubMed
Abstract available
Mast cell signaling and its role in urticaria.
Ann Allergy Asthma Immunol. 2024;133:374-379.
PubMed
Abstract available
Indications for extensively hydrolyzed cow's milk protein in the neonatal period.
Arch Pediatr. 2024 Jul 13:S0929-693X(24)00086.
PubMed
Abstract available
JSA-JSI Joint Session.
Arerugi. 2024;73.
PubMed
JSA-DGAKI Joint Meeting.
Arerugi. 2024;73.
PubMed
East Asia Allergy Symposium 2024.
Arerugi. 2024;73.
PubMed
Optimising inhaled therapy for patients with asthma.
BMJ. 2024;386:e080353.
PubMed
Stevens-Johnson syndrome/toxic epidermal necrolysis: initial assessment.
BMJ. 2024;386:e079986.
PubMed
Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema
Area and Severity Index to facilitate large-scale meta-analyses of molecular
data.
Br J Dermatol. 2024;191:637-639.
PubMed
Severe allergic contact dermatitis caused by methoxypropylamino cyclohexenylidene
ethoxyethylcyanoacetate.
Contact Dermatitis. 2024 Sep 21. doi: 10.1111/cod.14700.
PubMed
Extensive allergic contact dermatitis to dexpanthenol with distant facial and
symmetrical intertriginous involvement: An unusual clinical presentation.
Contact Dermatitis. 2024 Sep 16. doi: 10.1111/cod.14693.
PubMed
Baicalin Attenuates Type 2 Immune Responses in a Mouse Allergic Asthma Model
through Inhibiting the Production of Thymic Stromal Lymphopoietin.
Int Arch Allergy Immunol. 2024 Sep 19:1-9. doi: 10.1159/000541100.
PubMed
Abstract available
Sex-Specific and Long-Term Trends of Asthma, Allergic Rhinitis, and Atopic
Dermatitis in South Korea, 2007-2022: A Nationwide Representative Study.
Int Arch Allergy Immunol. 2024 Sep 16:1-18. doi: 10.1159/000540928.
PubMed
Abstract available
Disparities in Allergy and Asthma Prevalence Among School Teachers.
J Allergy Clin Immunol. 2024 Sep 18:S0091-6749(24)00978.
PubMed
Abstract available
Trained immunity-based vaccines for infections and allergic diseases.
J Allergy Clin Immunol. 2024 Sep 18:S0091-6749(24)00979.
PubMed
Abstract available
A retrospective cohort study investigating cutaneous vasculitis in the setting of
COVID-19 notes higher rates of IgA vasculitis.
J Am Acad Dermatol. 2024;91:757-759.
PubMed
Investigating corrected QT prolongation with hydroxychloroquine use among
patients with cutaneous sarcoidosis: A multicenter retrospective study.
J Am Acad Dermatol. 2024;91:740-742.
PubMed
Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety
results from two Japanese phase 3 trials.
J Dermatol. 2024 Sep 13. doi: 10.1111/1346-8138.17451.
PubMed
Abstract available
Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients
with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
PubMed
Abstract available
Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic
Health Database: a Cross-sectional Analysis.
J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
PubMed
Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
N Engl J Med. 2024;391:1067-1068.
PubMed
Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.
N Engl J Med. 2024;391:1066-1067.
PubMed
Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
N Engl J Med. 2024;391:1066.
PubMed
Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
N Engl J Med. 2024;391:1065-1066.
PubMed
Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis.
N Engl J Med. 2024;391:1065.
PubMed
Thank you for your interest in scientific medicine.